Serum p53 antibodies: predictors of survival in small-cell lung cancer?

Serum p53 antibodies have been shown to be a poor prognostic marker in resected non-small-cell lung cancer (NSCLC), but studies in small-cell lung cancer (SCLC) have been contradictory. We have studied the incidence of p53 antibodies in a large SCLC cohort treated at one oncology centre and correlat...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, P V, Soussi, T, O'Brien, M E R, Smith, I E, Brossault, S, Norton, A, Ashley, S, Tavassoli, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363416/
https://www.ncbi.nlm.nih.gov/pubmed/11076647
http://dx.doi.org/10.1054/bjoc.2000.1475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363416/
https://www.ncbi.nlm.nih.gov/pubmed/11076647
http://dx.doi.org/10.1054/bjoc.2000.1475

Ejemplares similares